Science with a strong commercial focus
We have assembled an experienced management team and a dedicated team of project managers and scientists to execute the Opsona strategy.
The Board of Directors at Opsona Therapeutics have a wealth of experience in the global pharmaceutical industry and includes biotechnology veterans, financiers and leading academics. The make-up of the board ensures that our company is underpinned by solid scientific foundations coupled with a strong commercial focus.
Founders
The academic founders of our company include leading immunologists - Professor Luke O'Neill and Professor Kingston Mills and leading translational gastroenterologist Professor Dermot Kelleher.
Our approach is endorsed by commercial partnerships with leading international pharmaceutical companies, including Wyeth/Pfizer, CSL and Merck.
Opsona also has a strong life-science focused investor base.
Links
Find out more about our management team.
Read more about our Scientific Advisory Board and our Board of Directors.